MARATTO

article · RSC Advances

Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive <i>in vitro</i> and <i>in silico</i> study

202417 citationsOpen accessSouth Valley University

Abstract

Compound 20b presents as a promising anti-proliferative agent targeting VEGFR-2. Also, this comprehensive investigation underscores the potential of 2,3-dihydro-1,3,4-thiadiazole derivatives as promising candidates for further development in anti-cancer research.

Research topics

  • Angiogenesis and VEGF in Cancer
  • Synthesis and biological activity
  • HER2/EGFR in Cancer Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1039/d4ra04158e

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.